RO7049389, a core protein allosteric modulator, is safe and well tolerated in healthy volunteers and demonstrates potent anti-HBV activity in a phase 1 trial

著录项

• 来源
  《Journal of viral hepatitis.》 |2018年第s2期|共2页
• 作者

  Gane E.; Liu A.; Yuen M-F; Schwabe C.; Bo Q.; Das S. K.; Gao L.; Zhou X.; Wang Y.; Coakley E.; Jin Y.;

  展开▼
• 作者单位

  Auckland Clin Studies Auckland New Zealand;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  Univ Hong Kong Med Hong Kong Hong Kong Peoples R China;

  Auckland Clin Studies Auckland New Zealand;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  Roche Prod Ltd Welwyn Garden City Herts England;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  Roche Innovat Ctr New York NY USA;

  Roche Innovat Ctr Shanghai Shanghai Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 传染病;
• 关键词